Tim Raine

18.7k total citations · 3 hit papers
97 papers, 4.9k citations indexed

About

Tim Raine is a scholar working on Genetics, Epidemiology and Immunology. According to data from OpenAlex, Tim Raine has authored 97 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Genetics, 38 papers in Epidemiology and 24 papers in Immunology. Recurrent topics in Tim Raine's work include Inflammatory Bowel Disease (43 papers), Microscopic Colitis (31 papers) and Eosinophilic Esophagitis (9 papers). Tim Raine is often cited by papers focused on Inflammatory Bowel Disease (43 papers), Microscopic Colitis (31 papers) and Eosinophilic Esophagitis (9 papers). Tim Raine collaborates with scholars based in United Kingdom, United States and Canada. Tim Raine's co-authors include Rami Eliakim, Marcus Harbord, Herbert Tilg, Alexander R. Moschen, Anne Cooke, Jimmy K. Limdi, Fernando Magro, Ailsa Hart, Johan Burisch and Sandro Ardizzone and has published in prestigious journals such as Cell, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Tim Raine

86 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders

2017 1.3k citations Tim Raine et al. Journal of Crohn s and Colitis profile →
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management

2017 854 citations Tim Raine et al. Journal of Crohn s and Colitis profile →
IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting

2018 353 citations Tim Raine et al. profile →

Peers

Countries citing papers authored by Tim Raine

Since Specialization

Citations

This map shows the geographic impact of Tim Raine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Raine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Raine more than expected).

Fields of papers citing papers by Tim Raine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Raine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Raine. The network helps show where Tim Raine may publish in the future.

Co-authorship network of co-authors of Tim Raine

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Raine. A scholar is included among the top collaborators of Tim Raine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Raine. Tim Raine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	DOP112 Inflammation-associated monocytes express ACOD1 to curtail inflammatory behaviour in IBD and experimental colitis 2025 ·Journal of Crohn s and Colitis ·Gareth Jones, (unknown), (unknown), (unknown), (unknown), Tim Raine, Adam J. Byrne, Carl A. Anderson, Gwo‐Tzer Ho, Calum C. Bain	0
2	Splicing QTL mapping in stimulated macrophages associates low-usage splice junctions with immune-mediated disease risk 2025 ·Nature Communications ·(unknown), Nikolaos I. Panousis, Andrew Knights, Natsuhiko Kumasaka, Maria Imaz, (unknown), A. Tsingene, Alex Tokolyi, Cristina Cotobal, (unknown), (unknown), Tim Raine, A Barnett, Céline Gomez, Daniel J. Gaffney, Carl A. Anderson	1
3	Matching-adjusted indirect comparisons of efficacy outcomes between etrasimod and ozanimod for moderately to severely active ulcerative colitis 2025 ·Journal of Comparative Effectiveness Research ·Vipul Jairath, Tim Raine, Thomas P. Leahy, Ravi Potluri, Karolina Wosik, David Gruben, Joseph C. Cappelleri, Peter Hur, (unknown)	0
4	DOP64 Steroid-sparing effect of risankizumab vs ustekinumab in patients with moderately to severely active Crohn’s Disease: Post hoc results from the phase 3b SEQUENCE trial 2024 ·Journal of Crohn s and Colitis ·Tim Raine, Silvio Danese, Stefan Schreiber, Xiang Gao, Stephen B. Hanauer, Joana Torres, Kristina Kligys, Xiu Huang, Ezequiel Neimark, (unknown), John Crowley, Raymond K. Cross	2
5	Fine-mapping and molecular characterisation of primary sclerosing cholangitis genetic risk loci 2024 ·Nature Communications ·Elizabeth C. Goode, Laura Fachal, Nikolaos Panousis, Loukas Moutsianas, Rebecca E. McIntyre, (unknown), Norihito Kawasaki, Alexandra Wittmann, Tim Raine, Simon Rushbrook, Carl A. Anderson	1
6	Trends in Systemic Glucocorticoid Utilization in the United Kingdom from 1990 to 2019: A Population-Based, Serial Cross-Sectional Analysis 2024 ·PubMed ·Andrew Menzies‐Gow, Trung N. Tran, (unknown), Victoria Carter, Josef S Smolen, Arnaud Bourdin, James Fitzgerald, Tim Raine, (unknown), Benjamin Emmanuel, David J. Jackson, David Price	7
7	Impact of Baseline Corticosteroid Use on the Efficacy and Safety of Upadacitinib in Patients with Ulcerative Colitis: A Post Hoc Analysis of the Phase 3 Clinical Trial Programme 2023 ·Journal of Crohn s and Colitis ·Tim Raine, Yoh Ishiguro, David T. Rubin, Tricia Finney‐Hayward, (unknown), John Liu, Charles M. Phillips, (unknown), Laura E. Targownik, Edward V. Loftus	4
8	Dose Escalation Patterns of Advanced Therapies in Crohn’s Disease and Ulcerative Colitis: A Systematic Literature Review 2023 ·Advances in Therapy ·Remo Panaccione, Wan‐Ju Lee, (unknown), Kristina Kligys, Rhiannon I. Campden, Stacy Grieve, Tim Raine	13
9	Executive summary: The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs 2022 ·Lara D. Veeken ·Laura Tucker, Alexander Allen, David Chandler, Coziana Ciurtin, Andrew D. Dick, Amy Foulkes, Nicola Gullick, Philip Helliwell, Deepak R. Jadon, Gareth T. Jones, Stuart Kyle, Vishnu Madhok, Neil McHugh, Andrew Parkinson, Tim Raine, Stefan Siebert, Catherine Smith, William Tillett, Laura C. Coates	3
10	The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs 2022 ·Lara D. Veeken ·Laura Tucker, Alexander Allen, David Chandler, Coziana Ciurtin, Andrew D. Dick, Amy Foulkes, Nicola Gullick, Philip Helliwell, Deepak R. Jadon, Gareth T. Jones, Stuart Kyle, Vishnu Madhok, Neil McHugh, Andrew Parkinson, Tim Raine, Stefan Siebert, Catherine Smith, William Tillett, Laura C. Coates	9
11	POS0965 MAGNETIC RESONANCE ENTEROGRAPHY AS A SCREENING TOOL FOR AXIAL SPONDYLOARTHRITIS IN CROHN'S DISEASE: A PROSPECTIVE SINGLE-CENTER CROSS-SECTIONAL OBSERVATIONAL STUDY USING MRE SCREENING FOLLOWED BY CLINICAL ASSESSMENT (ProSpA-CD) 2022 ·Annals of the Rheumatic Diseases ·(unknown), Tim Raine, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
12	Maintaining Clinical Freedom Whilst Achieving Value in Biologics Prescribing: An Integrated Cross-Specialty Consensus of UK Dermatologists, Rheumatologists and Gastroenterologists 2021 ·BioDrugs ·Tim Raine, (unknown), Peter M. Irving, Arvind Kaul, Eleanor Korendowych, Philip Laws, Amy Foulkes	4
13	Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope 2020 ·Lara D. Veeken ·William Tillett, Alexander Allen, Laura Tucker, David Chandler, Coziana Ciurtin, (unknown), Andrew D. Dick, Amy Foulkes, Nicola Gullick, Philip Helliwell, Deepak R. Jadon, Gareth T. Jones, Stuart Kyle, Vishnu Madhok, Neil McHugh, Andrew Parkinson, Tim Raine, Stefan Siebert, Catherine Smith, Laura C. Coates	3
14	Thiopurine monotherapy is effective in ulcerative colitis but significantly less so in Crohn’s disease: long-term outcomes for 11 928 patients in the UK inflammatory bowel disease bioresource 2020 ·Gut ·(unknown), Wendi Qian, (unknown), (unknown), (unknown), (unknown), Tim Raine, Miles Parkes	47
15	PTU-126 Probiotics for the prevention of necrotising enterocolitis in very-low-birth-weight infants: a meta-analysis of randomised controlled trials 2017 ·Nutrition ·(unknown), Tim Raine, (unknown), Gusztáv Bélteki	1
16	ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease—An Update 2016 ·Journal of Crohn s and Colitis ·Silvio Danese, Gionata Fiorino, Tim Raine, Marc Ferrante, Karen Kemp, Jarosław Kierkuś, Péter L. Lakatos, Gerassimos J. Mantzaris, C. Janneke van der Woude, Julián Panés, Laurent Peyrin‐Biroulet	171
17	Hepatic Shunting of Eggs and Pulmonary Vascular Remodeling in Bmpr2 +/− Mice with Schistosomiasis 2015 ·American Journal of Respiratory and Critical Care Medicine ·Alexi Crosby, Elaine Soon, Frances M. Jones, Mark Southwood, Leila Haghighat, Mark Toshner, Tim Raine, (unknown), Peiran Yang, Stephen D. Moore, Elisabet Ferrer, P.A. Wright, Mark L. Ormiston, R. James White, (unknown), David W. Dunne, Nicholas W. Morrell	20
18	RGS1 is a key regulator of human T cell migration and a potential target for therapy in Inflammatory Bowel Disease (IBD) 2010 ·Immunology ·Deena L. Gibbons, Tim Raine, Lucie Abeler‐Dörner, Anett Jandke, (unknown), Peter M. Irving, John H. Kehrl, Adrian Hayday	2
19	Cyclophosphamide-Induced Type-1 Diabetes in the NOD Mouse Is Associated with a Reduction of CD4+CD25+Foxp3+ Regulatory T Cells 2006 ·The Journal of Immunology ·Sven Brode, Tim Raine, Paola Zaccone, Anne Cooke	143
20	Cutting Edge: Leukocyte Receptor Complex-Encoded Immunomodulatory Receptors Show Differing Specificity for Alternative HLA-B27 Structures 2001 ·The Journal of Immunology ·Rachel Allen, Tim Raine, Anja Haude, John Trowsdale, Michael J. Wilson	135

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact